Clinical studies recruiting near Cerritos

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Local Institution - 0044 · Bristol-Myers Squibb · NCT06929273 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · TOI Clinical Research · Loxo Oncology, Inc. · NCT05254743 Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 3 · Helios CR Inc./RadNet · SOFIE · NCT07217717 Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological
Phase 1 · TOI Clinical Research · Acrotech Biopharma Inc. · NCT07036133 Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Te
Phase 1/Phase 2 · The Oncology Institute of Hope and Innovation · Boehringer Ingelheim · NCT06324357 Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT06568367 A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Phase 1/Phase 2 · Helios Clinical Research · DualityBio Inc. · NCT05150691 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · The Oncology Institute of Hope and Innovation - Corporate Of · Mirati Therapeutics Inc. · NCT04613596 Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Phase 3 · Onco Inst of Hope and Innovation · Novartis Pharmaceuticals · NCT05827081 NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07114874 Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Phase 3 · Helios CR Inc./RadNet · SOFIE · NCT07217704 A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Che
Phase 3 · The Oncology Institute Of Hope And Innovation · Jazz Pharmaceuticals · NCT06435429 52-week Open Label Safety-Tolerability Study
Phase 3 · Synapse Clinical Trials · LB Pharmaceuticals Inc. · NCT07369154 A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recu
Phase 2/Phase 3 · Helios Clinical Research · Bristol-Myers Squibb · NCT06926868 A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, f
Phase 2 · The Oncology Institute of Hope and Innovation · Janssen Research & Development, LLC · NCT06667076 Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Phase 1/Phase 2 · Private Practice - Dr. Francisco Badar- Site Number : 840006 · Sanofi Pasteur, a Sanofi Company · NCT06316297 A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Phase 2 · Synapse Clinical Trials · Kynexis B.V. · NCT07191483 ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Phase 3 · The Oncology Institute (TOI) Clinical Research - 1109 · OncoC4, Inc. · NCT05671510 A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Phase 3 · Local Institution - 0014 · Bristol-Myers Squibb · NCT06951698 Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT06767514 Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Phase 3 · The Oncology Institute of Hope & Innovation · Summit Therapeutics · NCT05899608 A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Phase 3 · TOI Clinical Research · Astellas Pharma Global Development, Inc. · NCT06901531 A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Plac
Phase 3 · Core Healthcare Group · Paradigm Biopharmaceuticals Ltd. · NCT06917404

Look up another city

Look up another condition